SODIUM CHLORIDE, ARO-DUX4
ARODUX4-1001
Phase 2 small_molecule active
Quick answer
SODIUM CHLORIDE, ARO-DUX4 for Facioscapulohumeral muscular dystrophy (FSHD) is a Phase 2 program (small_molecule) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Facioscapulohumeral muscular dystrophy (FSHD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active